A novel fluorescence assay for phospholipase A2 [Wilton (1990) Biochem. J. 266, 435-439] has been used to study the Group-II rat liver mitochondrial enzyme, and a number of novel properties of this enzyme were identified. (1) The enzyme activity was located in the liver macrophages (Kupffer cells) while negligible activity was associated with hepatocytes. (2) Although subcellular fractionation of whole liver confirmed the predominantly mitochondrial location of this enzyme activity, the analysis of the hepatocyte-free Kupffer-celI-enriched fraction revealed a different enzyme distribution, with the majority of activity being associated with the microsomal membrane fraction. (3) 
INTRODUCTION
The enzyme phospholipase A2 (PLA2; EC 3.1.1.4) is of considerable interest because of its possible role in a number of biological phenomena. These processes include (a) signal transduction and the generation of eicosanoids and other cellular mediators [1] , (b) the remodelling of the fatty acyl chains of fatty acids in phospholipids, including the removal of oxidatively damaged fatty acids [2, 3] , and (c) the degradation of invading micro-organisms and necrotic tissue [41, in addition to the wellestablished digestive function of the enzyme from pancreas. The ability of PLA2 to release arachidonic acid as the controlling step in the biosynthesis of the eicosanoids and platelet-activating factor by most tissues of the body has focused much attention on the potential role of this enzyme in inflammatory processes [5] including the condition of septic shock [6] . The level of Group-II serum PLA2 is dramatically increased in animals treated with bacterial endotoxin [5] . It is also known that Kupffer cells in liver are a major site for removal of endotoxin [7] .
A continuous fluorescence-displacement technique has been developed that allows the rapid assay of PLA2 and lipases that release long-chain fatty acids. The versatility of this assay has been established with pure enzymes [8] [9] [10] . We wished to evaluate the use of this assay for measurement of phospholipases in crude fractions from homogenized tissues and cells in culture. The hepatocyte was chosen as an appropriate system for the measurement of PLA2 activity using the fluorescence assay because of the injection of endotoxin into rodents results in elevated serum phospholipase A2 activity, while a similar phenomenon is seen in the condition of septic shock in man. The source of this serum enzyme was unknown. In this study perfusion of livers from rats pretreated with lipopolysaccharide with physiological saline demonstrated a 6-fold increase in phospholipase A2 activity in the perfusate compared with sham-treated controls, with only minor release of hepatic lipase. (5) Western-blot analysis confirmed an increased release of this into the perfusate of lipopolysaccharide-treated rats compared with sham-treated controls. These results suggest that liver Kupffer cells are a major source of the endotoxin-induced serum Group-II phospholipase A2 activity associated with bacterial infection and trauma.
relatively high specific activity of the Group-II liver mitochondrial PLA2 [11] .
We now demonstrate that the liver mitochondrial PLA2 activity [11] -is located in Kupffer cells of the liver and not in hepatocytes.
Moreover, the activity was not primarily mitochondrial but had a more general membrane distribution. PLA2 activity was greatly enhanced on lipopolysaccharide (LPS) treatment in vivo, supporting a Kupffer cell location of this enzyme. Liver perfusion studies indicated the potential of this enzyme to be released into the serum under physiological or pathological conditions. Thus, Kupffer cells in liver may be a major source of the elevated serum PLA2 that is seen under conditions producing trauma, particularly septic shock [12] . The homogenate was centrifuged at 500 g for 5 min to sediment cell debris. The supernatant was centrifuged at 12000 g for 10 min and the resulting pellet designated the mitochondrial fraction. The post-mitochondrial supernatant was centrifuged at 105000 g for 60 min, the supernatant discarded and the resulting pellet was designated the microsomal fraction.
EXPERIMENTAL

Preparation of hepatocytes and Kupffer-cell-enriched fractions
Rat liver hepatocytes and Kupffer-cell-enriched fractions were prepared using a modified collagenase-perfusion technique [13] . Subsequent to collagenase perfusion, the liver was removed and cut into small pieces. (10 mM Tris/HCI, pH 7.5,0.154 M NaCl, 0.2 % sodium azide) containing 5 g of non-fat dry milk. Blots were washed three times for 10 min each wash with Tris-buffered saline and subsequently incubated in 25 ml of a 1: 500 dilution of a monoclonal antibody raised to rat liver mitochondrial PLA2 ( [11] , kindly provided by Dr. Henk van den Bosch) for 1-2 h at room temperature. Subsequently, the blot was washed four times (for 10 min each wash) with 30 ml of Tris-buffered saline containing 0.5 ml/l Tween-20 and no sodium azide. The blot was treated for 1-2 h with sheep anti-(mouse IgG) peroxidase (1: 5000) in the Tween-20 buffer. The blot was then washed four times for 5 min with the Tween buffer, then once for 15 min. The blots were incubated for 1 min in 20 ml of enhanced chemiluminescent Western-blotting detection reagent and subsequently exposed to X-ray film for 30 s. In some experiments, rat liver perfusate (50 ml) from sham-operated (control) and LPS-treated rats was concentrated to 3 ml as described above and Western-blot analysis performed on aliquots of the crude perfusate that were subjected to SDS/PAGE.
Release of PLA2 from membrane fractions was maintained throughout this period (2-4 min) to provide an initial perfusate of 20 ml after which a 50 ml sample of Hanks Membrane fractions obtained by centrifugation were resuspended in a buffer containing 250 mM sucrose, 20 mM Tris/HCI, Rat liver phospholipase A2 145 pH 7.4, 1 mM EDTA and 1 M KCl with five strokes of a dounce homogenizer. Typically the liver mitochondrial fraction was suspended to give a total volume of 10 ml. Samples, 2 x 0.5 ml, were placed in 11 mm x 34 mm centrifuge tubes and sonicated for 2 x 15 s using a Heat Systems-Ultrasonics W-385 sonicator fitted with a microtip probe on a power setting of 2. The samples were centrifuged at 350000 g for 15 min in a Beckman TL-100 ultracentrifuge and the supernatant (2-50,tl) was assayed.
Assay of PLA2 activity The procedure used was essentially that described previously [8] . The assay cocktail (1 ml) contained 1.116 ,uM 11-(dansylamino)undecanoic acid and 0.01 mg/ml DOPG in 0.1 M Tris/HCl, pH 8.0, containing 0.1 M NaCl and 2.5 mM CaCl2.
The 70 % satn. (NH4)2SO4 supernatant, obtained during purification of recombinant rat liver fatty-acid-binding protein, or pure protein [17] (at a concentration of about 10 ,ug/ml) were used in these studies. Calibration was performed by adding up to 1 nmol of oleic acid as a 1 mM solution prepared in methanol. EGTA, when used, was added at a final concentration of 5 mM to this assay. Enzyme fractions (2-50 jul) were added to the complete assay and the initial rate of fall in fluorescence was recorded. Fluorescence measurements were made at 25°C in 4 ml polystyrene fluorimeter cells using an Hitachi F2000 fluorimeter fitted with an external recorder.
Other analyses Protein was estimated by the Bradford method [18] . Student's ttest was used for determination of significance. The level of significance was defined as P < 0.05. Table 1 Distribution of the KCI-releasable PLA4 acftvity of rat liver Liver fractions were prepared as described in the Experimental section and the peripheral PLA2 was released by sonication in the presence of 1 M KCI. PLA2 activity was determined in the supernatant after sonication using DOPG as substrate. Values represent the mean + S.D. Values in parentheses indicate number of separate experiments performed. For PLA2 activity 1 m-unit is defined as 1 nmol of DOPG hydrolysed/min in the fluorescence assay after subtraction of the rate in the presence of EGTA. In one experiment the distribution of total KCI-releasable activity was determined between hepatocytes, the non-hepatocyte cell fraction and the celldebris fraction. The percentage of total distribution was hepatocytes (2%), non-hepatocyte cell fraction (30%) and cell-debris fraction (68% 
RESULTS
Assay of liver PLA2 activity
Liver mitochondria were prepared and solubilized by sonication in the presence of 1 M KCl following essentially the method of Aarsman et al. [11] . Enzyme activity in the supernatant was measured by the fluorescence assay using DOPG as substrate. We have previously shown that DOPG is a preferred substrate for the liver mitochondrial PLA2 using the fluorescence assay [19] and in the present study DOPG showed activity approx. 1000 times greater than with dioleoylphosphatidylcholine, when measured under identical assay conditions. High PLA2 activity was released from the liver mitochondria after sonication (Table 1) although no significant activity was released by sonication in the absence of 1 M KC1. This released activity could be inhibited by over 90 % in the presence of excess EGTA, consistent with a PLA2 which requires Ca2+ as an essential component of the catalytic mechanism. The solubilized activity, when fractionated on a Sephadex G-75 column, was detected in the low-molecular-mass fraction of the column effluent consistent with the 14 kDa mass of mitochondrial PLA2 [11] . The total liver mitochondrial activity for this enzyme under these assay conditions was about 400 m-unit for 125 g male rats.
The presence or absence of Ca2+ in the homogenizing buffer could affect the subcellular distribution of this PLA2 during cell disruption. Therefore, in one experiment, samples from the same liver were homogenized either in the presence of EDTA (normal protocol) or without EDTA and in the presence of 1 mM Ca2 . The specific activities of the KCl-released mitochondrial associated enzymes were 15.4 and 14.9 nmol/min per mg after homogenization in the absence or presence of Ca2+ respectively. Thus, Ca2+ appears to have no effect on the subcellular location of this enzyme after cell disruption.
The microsomal fraction was also solubilized and tested for PLA2 activity (Table 1 ). Low levels of activity were detected, consistent with a previous report [11] . Phospholipase activity was relatively insensitive to EGTA, indicating the presence in this fraction of other Ca2+-independent lipases. The other relatively abundant phospholipase activity in liver is hepatic lipase. This 53 kDa protein, which does not have an absolute requirement for Ca2 , is readily assayed with the fluorescence method using DOPG as substrate. About 1000 m-unit of this activity was released by heparin in liver perfusion studies (results not shown). Mono-oleoylglycerol is a well-documented substrate for hepatic lipase [20] and showed similar activity to DOPG in the fluorescence assay. The KCl-released liver mitochondrial enzyme was completely inactive with this substrate in the fluorescence assay.
Thus, although the fluorescence assay is non-specific and detects the release of long-chain fatty acids, the properties of the KCl-releasable liver mitochondrial activity confirm that it is the PLA2 described by Aarsman et al. [11] .
Cellular distribution of liver PLA2
Liver contains hepatocytes and other non-parenchymal cells of which Kupffer cells, the resident macrophage cells of the liver, are the most abundant. Collagenase perfusion of liver allows the preparation of virtually pure samples of hepatocytes and, by further differential centrifugation, a sinusoidal cell fraction that contained the Kupffer cells. Following this procedure relatively large amounts of these two cell types could be prepared rapidly and subjected to homogenization and subcellular fractionation before assay for PLA2 activity.
Significant liver mitochondrial PLA2 activity could not be detected in hepatocytes using the fluorescence assay (Table 1) . Figure 1 .
Each bar represents the average of duplicate measurements from two rats.
Hovever, high levels of activity were present in the Kupffer-cellenriched fractions (Table 1 ) and this activity was 98-100 00 inhibited by EGTA. An additional observation was that the majority of enzyme activity and the highest specific activity was found in the microsomal fraction of the Kupffer-cell-enriched fraction.
The Kupffer-cell-enriched fraction accounted for about 30 of the total PLA2 activity in this non-hepatocyte-containing residue after liver disruption. The majority of the PLA. activity was in the membrane fractions derived from the 300g supernatant (cell-free debris fraction). Differential centrifugation of this cell debris fraction also gave a preferential distribution of PLA., activity in the microsomal fraction ( Table 1) .
Assay of PLA2 activity in pure Kupffer cells The Kupffer cell fraction described above would contain other small cells from the liver including lipocytes and endothelial cells.
When the PLA, activity was measured in highly purified Kupffer cells high PLA., activity was observed (Table 1) which was completely inhibited with EGTA. This result confirms a Kupifer cell location of this liver PLA,. After these studies were completed, Inada et al. [21] reported a preferential distribution of PLA. activity in Kupffer cells.
Effect of LPS on liver PLA2 activity
Kupffer cells play a major role in the removal of LPS (bacterial endotoxin) in the rat while endotoxin challenge is associated with elevated levels of non-pancreatic serum PLA2 in many species, including man [6] . Having identified high levels of liver PLA., in the Kupifer cell fraction it was of particular interest to investigate how this enzyme activity responded in i1ro to administration of LPS.
In Figure I we demonstrate the dramatic time-dependent effect of LPS injection on liver PLA2 activity, showing a 10-fold increase after 8 h compared with saline-injected controls. A significant increase was also seen in saline-injected controls after 4 h, suggesting that even the minor trauma of intraperitoneal injection of a significant volume of saline may stimulate the activity of this enzyme.
In order to determine the effect of lower doses of LPS on PLA., activity, rats were injected with saline or various concentrations of LPS and 4 h later the liver was removed and PLA, activity assayed. As seen in Figure 2 the effect of LPS on rat liver PLA, activity was concentration-dependent.
When livers from LPS-treated rats (4 h exposure) were subjected to collagenase perfusion and cell fractionation, it was impossible to obtain discrete fractions of hepatocytes and nonparenchymal cells due to cell clumping. Therefore, it was not possible to demonstrate enhanced levels of PLA., activity in the Kupffer cell fraction. After these studies were completed, Inada et al. [22] reported stimulation of PLA., by LPS in both hepatocytes and non-parenchymal cells.
Is liver PLA2 activity released during perfusion?
As well as the classic example of PLA., release from platelets [23] a number of mammalian cells in culture have now been shown to release PLA, [24] [25] [26] [27] . Therefore, it was important to investigate the possible release of PLA 2 from the liver in view of the similarity to PLA2 from rat spleen and platelets [27] . Both of these enzymes have a cleavable signal sequence, suggesting export [28, 29] .
Liver perfusions were performed on 4 h LPS-treated and sham-treated control rats, since this has been observed to be the time at which serum PLA2 reaches its maximum level after LPS injection in rabbits [5] . After an initial 20 ml perfusion to remove blood components, a 50 ml perfusion (10-12 min) was collected and, after concentration, subjected to fractionation on a or protein, were subjected to SDS/PAGE followed by Western-blot analysis with antibody raised to rat liver PLA2. Abbreviation: df, dye front.
Livers from LPS-injected (LPS) or saline-injected (Sham) rats were perfused and the perfusate concentrated as described in the Experimental section. The concentrated suspension was applied to a Sephadex G-75 column and proteins eluted. Traces are shown for both saline-and LPS-injected rats and are the average of two separate liver perfusions. Total releasable PLA2 activity, collected in fractions 11-18, was 156 m-unit for LPS-injected rats and 27 m-unit for saline-injected controls. The PLA2 activities from all rats was 100% inhibited by EGTA.
Sephadex G-75 column to separate PLA2 activity from the heparin-releasable hepatic lipase which is also released to a small extent from liver in the absence of heparin. The results of such fractionations for control and LPS-treated liver perfusates are shown in Figure 3 and clearly demonstrate an enhanced release of PLA2 activity (fractions 12-15) after LPS treatment. The initial peak (fractions 8-10) is hepatic lipase which was dramatically enhanced (20-fold) by addition of heparin to the perfusion buffer (results not shown). The total PLA2 activity released from LPS-treated liver in 10-12 min of perfusion (about 150 m-unit) represented about 6 % of the total mitochondrialassociated activity (2500 m-unit) in these livers. This remarkable rate of loss would suggest a physiological release process rather than liver damage. This conclusion is supported by lactate dehydrogenase levels which were low in the total perfusate of both sham-operated control (0.21 unit) and LPS-treated (0.26 unit) rats. Of interest was the appearance of a yellow protein(s) in the fractions eluting between hepatic lipase and PLA2 which showed absorbance at 414 nm. The release of this chromophore paralleled the release of PLA2. The nature of this protein remains to be established but could be related to the respiratory burst oxidase of macrophages [30] . SDS/PAGE followed by Western-blot analysis was performed on the 50 ml fraction concentrated by Sephadex G-75 chromatography. The results clearly showed cross-reaction of the 14 kDa band with the rat liver PLA2 antibody (Figure 4, lanes 1 and 2) . . . . . . . . . . . . . . . . . -. . . . . . . . . . . . 
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Figure 5 SDS/PAGE analysis of proteins released into the perfusate Rats were treated with LPS (10 mg/kg) or saline (sham) and 4 h later their livers were perfused with 50 ml of Hanks balanced salt solution. The 50 ml perfusate was concentrated to 3 ml using poly(ethylene glycol). Subsequently, increasing equivalent volumes of perfusate from each group were analysed by SDS/PAGE as described in the Experimental section. Lanes 1, 3, 5 and 7, sham; lanes 2, 4, 6 and 8, LPS-treated. Gel loading: lanes 1 and 2, 5 ,ul; lanes 3 and 4, 10 ,ul; lanes 5 and 6, 15 ,ul; lanes 7 and 8, 20 ul of concentrated perfusate. The protein concentration was 0.6 aug/aul and 1.2 ag/aul of sham-treated control and LPS-treated groups respectively.
The bands appeared quite diffuse in this analysis and this was probably due to the high concentration of KCl present in the Sephadex G-75-concentrated perfusate before electrophoresis. Despite the diffuse nature of the bands the antibody response was clearly concentration-dependent and restricted to the 14 kDa region of the gel.
To determine whether the amount of PLA2 released into the perfusate was altered in LPS-treated rats compared with sham- df- Figure 6 Western-blot analysis of PLA2 released Into the perfusate Rats were treated with LPS or saline and 4 h later the livers were perused and the perfusate concentrated and subjected to SDS/PAGE as described in the legend to Figure 4 , except that equivalent amounts of protein from sham-treated control or LPS-treated rat perfusates were analysed. Subsequently, Western-blot analysis was performed using antibody raised to rat liver PLA2 as described in the Experimental section. treated controls, SDS/PAGE followed by Western-blot analysis was performed on 50 ml of liver perfusate that was concentrated from these rats. SDS/PAGE revealed a significant 2-fold increase in release of protein ( Figure 5 ). This was confirmed by Bradford protein estimation [18] . When equivalent amounts of protein were subjected to SDS/PAGE followed by Western-blot analysis using antibody raised to rat liver PLA2, a significantly larger amount of PLA2 was released from the liver into the perfusate of LPS-treated rats compared with sham-treated controls ( Figure  6 ).
DISCUSSION
With the continuous fluorescence-displacement assay, we confirmed the results of Aarsman et al. [11] for both the mitochondrial location of this PLA2 in liver homogenates and its release after sonication in 1 M KCI. We established that isolated hepatocytes did not contain this activity, which was found in the Kupffer cells. In addition, we demonstrated that the release of PLA2 and its activity was greatly enhanced during endotoxin treatment in vivo, indicating the potential of this enzyme to be released into the serum. The high specific activity of the liver mitochondrial PLA2 put the measurement of this enzyme well within the sensitivity range of the fluorescence-assay method. The fluorescence-displacement-assay method has a lower sensitivity of about 0.02 m-unit of enzyme activity per ml of assay mixture under optimal conditions. However, sensitivity is compromised if membrane fractions are measured. This is because the fluorescent fatty-acid probe that is used will partition into the membranes and give a high background fluorescence. Therefore, the fact that the liver mitochondrial enzyme is readily released from membrane fractions by sonication in 1 M KCI greatly facilitates the assay of this enzyme [11] .
A surprising feature of the activity, in both the Kupffer-cellenriched fraction and the debris obtained after collagenase treatment, was that the majority of this activity was not found in the mitochondrial fraction but was located in the postmitochondrial membrane fractions, which would include smaller granules and microsomes. An identical homogenization procedure was used as for the preparation of the mitochondrial fraction from whole liver. The explanation of the different distribution in these systems probably reflects the cells being homogenized. One We have observed previously that DOPG is a preferred substrate for liver PLA2, and we have observed a similar preference with the recombinant human-platelet-derived enzyme. Using the fluorescence assay, the expressed activity was in the order DOPG > dioleoylphosphatidylethanolamine > dioleoylphosphatidylcholine [19] . This preference for the negatively charged DOPG may have physiological significance that reflects the probable degradative role of the enzyme. This macrophage-derived PLA2 would preferentially degrade negatively charged phospholipids that are exposed in broken or permeabilized cells of host or bacterial origin. A similar phosphatidylglycerol preference has been observed for PLA2s from pig intestine [31] and rat spleen [32] . The spleen enzyme is also associated with phagocytic cells [21, 22] .
The level of serum PLA2 is dramatically increased in vivo by treatment with endotoxin [5] . Moreover Kupffer cells are a major site of removal of this LPS in rat [7] , possibly as a result of uptake via the macrophage scavenger system [33] . Therefore, the effect of LPS treatment on the PLA2 activity in the liver and isolated cell fractions was investigated. A dramatic 6-fold enhancement of liver PLA2 activity was observed after 4 h. The characteristics of this enhanced enzyme activity were identical to normal liver mitochondrial-associated PLA2 activity. It was not possible to obtain discrete cell fractions after collagenase perfusion of livers from LPS-treated animals, possibly due to a significant disruption of the cellular integrity of the liver by LPS.
A major question in inflammation research is the origin of the elevated serum PLA2 levels observed after infection or trauma, particularly septic shock. An obvious candidate is the releasable platelet PLA2. However, according to the calculations of Aarsman et al. [11] the total mitochondrial-associated PLA2 activity is similar to that of total platelet activity. The ability of LPS to enhance the liver PLA2 activity many fold focuses attention on the Kupffer cell enzyme as a major source of serum Rat liver phospholipase A2 149 PLA2 in the traumatized rat. The greatly enhanced loss of PLA2 in the perfusates of livers from animals previously injected with LPS supports this proposal and is quantitatively high enough to produce elevated serum levels of the enzyme. There are now many precedents for the stimulation and release of PLA2 from cells by various mediators, including cytokines and plateletactivating factor. A role for LPS has been directly implicated in PLA2 expression in murine macrophage-like P338D1 cells [34] . In addition, it has recently been reported that HepG2 cells respond to various cytokines, and in particular interleukin-6, by expressing and releasing PLA2 in parallel to the release of acutephase proteins [26] . The fact that HepG2 cells are derived from human hepatocytes rather than liver macrophages will require clarification.
It should be noted that whereas Kupffer cells represent a major site of endotoxin removal in rats, in some species other macrophage-containing organs such as lung play a more dominant role [7] . The macrophages resident in other tissues must also be considered as additional/alternative sources of serum PLA2 during trauma, depending on the nature of the trauma and the animal species.
If, as appears to be the case, this release of PLA2 by the liver is a physiological or pathophysiological phenomenon then the precise function or effect of the serum PLA2 is obscure. Certainly injected PLA2 is able to release arachidonic acid in tissues as the first step in eicosanoid synthesis. Moreover, addition of this PLA2 to cells in culture produces increased synthesis of prostanoids; however, this is only observed in activated or damaged cells [35, 36] . Therefore, it is possible that enhanced levels of this Group-II PLA2 in serum as a result of trauma may provoke an excessive inflammatory response by hydrolysing the membrane phospholipid of suitably modified or damaged tissues to release archidonic acid or other biologically active lipids. However, it is now accepted that the enzyme which normally mediates eicosanoid synthesis is the high-molecular-mass arachidonic-acidspecific cytosolic PLA2 [37, 38] .
Alternatively, the elevated serum PLA2 may play a role in the degradation of invading bacteria or damaged cells in the blood. Functionally this PLA2 shows a similarity to the pancreatic enzyme in terms of its preference for DOPG [9] . Moreover, the pancreatic enzyme will bind essentially irreversibly to negatively charged phospholipids [39] but has low affinity for zwitterionic phospholipids such as phosphatidylcholine that predominate on the external surface of cell membranes. If the liver enzyme had similar binding characteristics, it would bind preferentially to damaged cells in the blood and not bring about the destruction of normal cells. This destruction may be the result of the uptake of this PLA2 into phagocytic cells in a 'piggy-back' fashion while still attached to damaged cell membranes and thus facilitates degradation within the macrophage [40] .
Further work will be required to clarify the mechanism of PLA2 stimulation by LPS challenge. However, there are a number of precedents based on studies with cultured cells which show that enhanced PLA2 activity upon stimulation by LPS and cytokines is associated with increased levels of mRNA for this Group-II enzyme [24] [25] [26] [27] . Since hepatocytes are the dominant type of cells in liver, Kupffer cells in culture rather than experiments involving whole liver should provide the best system for this future work. The potential difficulty with studies involving whole liver could explain the report that LPS injection did not apparently affect mRNA levels for this Group-II enzyme in rat liver [41] .
In conclusion, we have demonstrated using a rapid fluorescence assay that liver mitochondrial PLA2 is located in Kupffer cells, the resident macrophages of the liver, and that this enzyme activity is dramatically enhanced in vivo by endotoxin. The release of this enzyme in perfusion studies was also demonstrated and suggests that the liver may be a major source of serum PLA2 after trauma and infection. Thus, this macrophage-derived enzyme may play a pivotal role in a variety of clinical disorders including septic shock, adult respiratory distress system, psoriasis, renal failure, gout and arthritis where serum levels of PLA2 are elevated [5, 42] . The mechanisms and mediators of stimulation and release of enzyme activity from Kupffer cells remain to be established. The isolated perfused liver system together with cultured Kupffer cells should provide a useful model for this purpose. The possible role of the other small cells from the liver, lipocytes and endothelial cells, in PLA2 stimulation and release must also be investigated.
